COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,703 Articles (22,913 medRxiv, 8,790 bioRxiv)

Most recent first Previous |  Page 794: Articles 7931-7940  | Next

Seroprevalence of SARS-CoV-2 and risk factors in Bantul Regency, Yogyakarta, Indonesia
Ahmad, R. A., Indriani, C., Arisanti, R. R., Nanda, R. O., Mahendradhata, Y., Wibawa, T.
10.1101/2022.06.07.22276128 — Posted: 2022-06-09
Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay
Atchison, C. J., Moshe, M., Brown, J. C., Whitaker, M., Wong, N. C. K., Bharath, A. A., McKendry, R. A., Darzi, A., Ashby, D., Donnelly, C. A., Riley, S., Elliott, P., Barclay, W. S., Cooke, G., Ward, H.
10.1101/2022.06.08.22276154 — Posted: 2022-06-09
Estimating the within-person change in dental service access measures during the COVID-19 Pandemic
Semprini, J.
10.1101/2022.06.08.22276174 — Posted: 2022-06-09
Out-of-hospital Cardiac Arrest Before and During the COVID-19 Pandemic in the South Bronx
Biskupski, P., Ocrospoma Heraud, S., Khalil, M., Horoub, A., Maqsood, M., Ong, K., Cemalovic, N., Menon, V.
10.1101/2022.06.08.22276169 — Posted: 2022-06-09
Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
Wollants, E., Keyaerts, E., Cuypers, L., Bloemen, M., Thijssen, M., Ombelet, S., Raymenants, J., Beuselinck, K., Laenen, L., Budts, L., Pussig, B., Lagrou, K., Van Ranst, M., Andre, E.
10.1101/2022.06.08.22276091 — Posted: 2022-06-09
The effect of potential factors on all-cause and cause-specific and mortality: a pre-COVID-19 period review
Xu, J., Lin, Y., Tong, J., Zhou, Y.
10.1101/2022.06.08.22276123 — Posted: 2022-06-08
Development of a COVID-19 warning system for neighborhood-scale wastewater-based epidemiology in low incidence situations
Oh, C., Zhou, A., O'Brien, K., Jamal, Y., Shisler, J. L., Jutla, A., Schmidt, A., Keefer, L., Brown, W. M., Nguyen, T. H.
10.1101/2022.06.07.22276055 — Posted: 2022-06-08
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine
Yechezkel, M., Mofaz, M., Patalon, T., Gazit, S., Shmueli, E., Yamin, D.
10.1101/2022.06.07.22276117 — Posted: 2022-06-08
Long-term prognosis of adults with moderate-severe SARS-CoV-2 lower respiratory tract infection managed in primary care: prospective cohort study
Platteel, T., Koelmans, J., Cianci, D., Broers, N., Bont, E. d., Cals, J., Venekamp, R., Verheij, T.
10.1101/2022.06.07.22276108 — Posted: 2022-06-08
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants
Beavis, A., Li, Z., Briggs, K., Diaz, M., Wrobel, E., Najera, M., An, D., Orr-Burks, N., Murray, J., Pati, P., Huang, J., Mousa, J. J., Hao, L., Hsiang, T.-Y., Gale, M. J., Harvey, S., Tompkins, S. M., Hogan, J., Lafontaine, E., Jin, H., He, B.
10.1101/2022.06.07.495215 — Posted: 2022-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).